 Shares of Osmotica Pharmaceuticals NASDAQ: OSMT, a small-cap biopharmaceutical company, are down by 20.4 as of 11:26 a.m. EDT on Tuesday, following the companys announcement on Monday evening of the pricing of a public offering of common stock. Investors arent thrilled with the prospect of Osmotica resorting to dilutive forms of financing. Osmotica said it would offer 5 million shares to the public for 6.55 per share. 